Loading clinical trials...
Loading clinical trials...
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Givi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
City of Hope Medical Center
Collaborators
NCT06317649 · Acute Myeloid Leukemia
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT06191978 · Acute Myeloid Leukemia
NCT06311227 · Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant
NCT06299540 · Leukemia, Lymphocytic, Chronic, B-Cell
Banner Good Samaritan Medical Center
Phoenix, Arizona
City of Hope Comprehensive Cancer Center
Duarte, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions